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Abstract
Multicellular tumour spheroid (MCTS) cultures are excellent model systems for simulating the development and
microenvironmental conditions of in vivo tumour growth. Many documented cell lines can generate differentiated MCTS
when cultured in suspension or in a non-adhesive environment. While physiological and biochemical properties of MCTS
have been extensively characterized, insight into the events and conditions responsible for initiation of these structures is
lacking. MCTS are formed by only a small subpopulation of cells during surface-associated growth but the processes
responsible for this differentiation are poorly understood and have not been previously studied experimentally. Analysis of
gene expression within spheroids has provided clues but to date it is not known if the observed differences are a cause or
consequence of MCTS growth. One mechanism linked to tumourigenesis in a number of cancers is genetic instability arising
from impaired DNA mismatch repair (MMR). This study aimed to determine the role of MMR in MCTS initiation and
development. Using surface-associated N2a and CHLA-02-ATRT culture systems we have investigated the impact of
impaired MMR on MCTS growth. Analysis of the DNA MMR genes MLH1 and PMS2 revealed both to be significantly down-
regulated at the mRNA level compared with non-spheroid-forming cells. By using small interfering RNA (siRNA) against
these genes we show that silencing of MLH1 and PMS2 enhances both MCTS initiation and subsequent expansion. This
effect was prolonged over several passages following siRNA transfection. Down-regulation of DNA MMR can contribute to
tumour initiation and progression in N2a and CHLA-02-ATRT MCTS models. Studies of surface-associated MCTS
differentiation may have broader applications in studying events in the initiation of cancer foci.
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Introduction
First utilised by Sutherland et al [1–3] multicellular tumour
spheroid (MCTS) cultures have become ideal model systems for
studying many aspects of tumour growth and physiology [1].
Previous experimental approaches have shown that MCTS are
morphologically and characteristically similar to solid tumours
in vivo [1,2,4]. They are composed of symmetrically arranged
aggregates of cells in discrete proliferating, dormant and necrotic
populations and are subject to varying oxygen gradients, nutrient
deficiencies and acidosis making them physiologically unique from
standard 2-dimensional cultures. MCTS gene expression profiles
also vary from 2-dimensional cultures and often closely mimic
those of in vivo tumours [5,6]. The ability to grow malignant cells as
3-D aggregates is of particular interest and to date spheroids have
been used as important in vitro tumour model systems in several
areas of cancer research [4].
Numerous properties of MCTS have been studied including
metabolism [7], gene [5] and protein expression [8], growth
kinetics [9–11], radiation resistance [12,13] and drug therapy
[14,15]. There has been less insight, however, into the events and
conditions that are responsible for the initiation of these structures.
MCTS are formed by only a small subpopulation of cells during
surface-associated growth. The mechanisms governing the differ-
entiation between 2D culture and 3D MCTS are poorly
understood and elucidation of these mechanisms may provide
new insight into early events in tumourigenesis.
Tumour growth may be described as a process of cellular
evolution [16] involving both genetic mutation and natural
selection [17]. These processes are driven by numerous physio-
logical and biochemical changes that occur during the progression
of a healthy cell to a malignancy. Genetic mutations and
associated genomic instability have received particular attention.
Malignancy is characterised by the accumulation of a large
number of mutations that cannot be accounted for by the low rate
of spontaneous mutation typically found in somatic cells. This has
led to the notion that cancer cells acquire a mutator phenotype
early in malignant progression resulting from mutations in genes
associated with maintaining genomic stability [18]. Genetic
instability has been shown to play a crucial role in MCTS
physiology, contributing, for example, to resistance to chemother-
apeutic agents [5,19] however its role in the early stages of
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spheroid formation is yet to be defined. One such mechanism for
generating genetic instability is impaired DNA MMR. MMR
mechanisms exist to remove nucleotide mismatches and insertion-
deletion loops resulting from slippage of DNA polymerase during
DNA replication. In human cells MMR is governed by several
heterodimeric factors composed of at least six different proteins.
MSH2 forms a heterodimer with either MSH6 or MSH3 (named
MutSalpha and MutSbeta respectively). Both initiate the repair
process, the former recognising base-base mispairs and the latter
insertion-deletion loops. A heterodimer of MLH1 and PMS2
represents the major MutL activity in human cells and binds to the
mismatch recognition complexes facilitating repair [20–22].
Previous evidence shows that inherited mutations of MMR genes
are associated with high relative and absolute risk of cancer [23–
26]. Hereditary nonpolyposis colon carcinoma (HNPCC) for
example is associated with MMR deficiency and mutations in
several of the human DNA MMR genes, prominently MSH2 and
MLH1 [24,25,27,28].
Previous work by Francia et al [5,19] revealed modest down-
regulation of PMS2 in EMT-6 mouse tumour spheroids.
Subsequent work has shown partial down-regulation of PMS2 in
human cancer cell lines WM9, MDA-MB-231 and MDA-MB-
435.TO.1 grown as spheroids compared with sub-confluent
monolayer cultures and substantial down-regulation of MLH1,
PMS2 and, occasionally both genes, in human breast, prostate,
and ovarian cancer cell lines [19]. Other components of the MMR
system including MSH6 and MSH2 were also found to be
differentially down-regulated in spheroid cultures. This observa-
tion is paralleled by an increase in the mutagenesis of reporter
genes [29] and correlates well with the known physiology of
MCTS. However, it remains to be understood if DNA MMR may
contribute directly to the formation and growth of MCTS.
We have investigated the impact of down-regulated DNA
MMR on the differentiation and progression of MCTS. In the
present work, we have employed a murine neuroblastoma N2a
and human brain tumour CHLA-02-ATRT surface-associated cell
culture system and short inhibitory RNA (siRNA) gene silencing
techniques to knockdown two critical MMR genes. Our data show
that impaired MMR enhances MCTS initiation and progression,
suggesting MMR mechanisms are involved in the processes that
lead to the differentiation of MCTS during N2a and CHLA-02-
ATRT surface-associated culture.
Results
Formation of multicellular tumour spheroids
Murine neuroblastoma N2a and human CHLA-02-ATRT
(intracranial atypical rhabdoid tumour) cells spontaneously formed
MCTS when grown on adhesive tissue culture plastic. Spheroids
displayed a broad size distribution ranging from 30–600 mm in
diameter (Fig. 1A). Both cell lines exhibited an enhanced ability to
form spheroids over successive passages (Fig. 1B) with an
approximate quadrupling of spheroid number between passage 1
and 7 for N2a cells (P,0.004). Spheroids were not observed to
coalesce when dense. Live video microscopy indicated that
spheroids were clonal in nature, showing internal expansion of
spheroid structure as opposed to external aggregation of motile
cells associated with the plate surface.
Down-regulation of MLH1 and PMS2 in MCTS
To determine whether the MMR genes MLH1 and PMS2 are
differentially expressed in N2a and CHLA-02-ATRT MCTS we
carried out reverse transcription PCR (RT-PCR) analyses on
separated monolayer and spheroid-derived cells. Analysis revealed
marked down-regulation MLH1 and PMS2 expression in MCTS
compared with cells derived from the ‘non-spheroid-forming’ 2D
monolayer. Our data shows a moderate down-regulation of both
MLH1 and PMS2 in 10 day old spheroids compared with
monolayer cells (Fig. 2). A similar decreased expression of
MLH1 and PMS2 was detected in spheroid cells that had been
dissociated, re-seeded and cultured for a subsequent 10 day
period. The down-regulation of MLH1 and PMS2 observed in
Figure 1. Subpopulations of murine N2a and human CHLA-02-ATRT cells form multicellular tumour spheroids during surface-
associated culture. (A) Representative image of an N2a MCTS. N2a cells were plated at a density of 16103 cells per 60 mm dish and cultured under
standard conditions for 5 days. Tumour spheroids (S) were differentiated from monolayer cells (M) at 6 days and exhibited a rough 3-dimensional
appearance comparable to MCTS structures grown on non-adherent surfaces or in suspension. Scale bar = 100 mm. (B) MCTS production increased
with serial passage. N2a and CHLA-02-ATRT cells were plated at a density of 16103 cells per 60 mm dish and cultured for 6 days. MCTS number was
recorded. Cells were scraped from the dish surface, treated with non-enzymatic cell dissociation solution and strained over a 70 mm filter to produce a
single-celled suspension which was verified with a haemocytometer. New 60 mm dishes were plated with 16103 cells from this suspension and
cultured for a further period of 6 days. MCTS number was again recorded. This procedure was repeated for a total of 7 passages. Statistical differences
were calculated by Student’s t-test. Each bar represents the mean 6 s.e.m. for at least three independent experiments. Significant differences
(P,0.001) are indicated by asterisks (*).
doi:10.1371/journal.pone.0028123.g001
Mismatch Repair and Tumour Spheroids
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these experiments is comparable to previous work conducted on
different murine tumour cell lines grown as spheroids [5,19].
Impact of MMR gene silencing on MCTS initiation and
development
To investigate the effect of impaired DNAMMRon the initiation
and progression of N2a and CHLA-02-ATRTMCTS we employed
a siRNA silencing technique to knockdown the expression of the
MMR genes MLH1 and PMS2. Gene expression knockdown
was confirmed by RT-PCR (Fig. 3). Spheroid number and size
was determined 7 days post-transfection using low magnification
microscopy and image analysis software. Cultures transfected with
MLH1 and PMS2 siRNA exhibited enhanced MCTS formation
with a mean 225623.1 and 242635 spheroids per 60 mm plate
respectively for N2a, compared to control siRNA transfected cells of
133617.3 and a mean 88.565.6 and 84.766.6 respectively for
CHLA-02-ATRT compared to control siRNA transfected cells of
55.467.1 (Fig. 4A). We also observed an approximate 175% and
168% increase in the size of spheroids formed by transfected N2a
and CHLA-02-ATRT cultures respectively (Fig. 4B). We detected
no increase in spheroid number or size with cultures incubated with
scrambled negative control siRNA or with the transfection agent
only (data not shown).
Transfection experiments were repeated on the non-tumour
murine fibroblast cell line 3T3. We observed no spontaneous
formation of differentiated MCTS in control or transfected
cultures (data not shown).
In order to assess the duration of the effects induced by MLH1
silencing, transfected cultures were passaged at day 7 and reseeded
into new tissue culture plates. MCTS analysis was conducted 7
days thereafter and the cultures passaged once again. This
procedure was repeated for a total of 3 post-transfection passages.
N2a MLH1 siRNA transfected cultures were seen to retain an
statistically significant increased MCTS forming ability after 2
post-transfection passages, whereas CHLA-02-ATRT MLH1
transfected cultures showed a significant increase in MCT
Figure 2. Decreased expression of MLH1 and PMS2 in multicel-
lular tumour spheroids. N2a and CHLA-02-ATRT cells were grown for
10 days in 90 mm dishes to generate large numbers of MCTS. MCTS
were separated from the bulk monolayer culture using a 19 gauge
needle. Spheroids were dissociated using non-enzymatic cell dissocia-
tion solution and strained over a 40 mm filter to produce a single-celled
suspension. The remaining monolayer cells were scraped from the plate
surface and treated as above to produce a single-celled suspension.
Half of each of the spheroid and monolayer-derived cells were lysed
and total RNA extracted from both cell populations. Reverse
transcription PCR was conducted to analyse differences in MLH1 and
PMS2 gene expression between the dissociated spheroid (S) and non-
spheroid forming monolayer cells (M). A reduced expression of both
MLH1 and PMS2 was detected in spheroid cells compared to the bulk
monolayer cells. The remaining dissociated spheroid cells and non-
spheroid forming monolayer cells were re-seeded as separate
populations in new dishes and grown for a further 10 days. RT-PCR
was performed on RNA extracted from the entire cell population and
analysis revealed a similar decreased expression of MLH1 and PMS2 in
spheroid-derived cells compared to monolayer-derived cells. Beta actin
expression is shown to confirm equal sample loading.
doi:10.1371/journal.pone.0028123.g002
Figure 3. Confirmation of siRNA silencing activity. N2a and CLHA-02-ATRT cells at 50% confluence were transfected with 30 nM siRNA
targeted against MLH1 and PMS2 and a negative control scrambled siRNA for a period of 5 hours. At 72 hours post-transfection cells were lysed and
total RNA extracted. Reverse transcription PCR analyses were conducted and confirmed successful knockdown of MLH1 and PMS2 expression in both
cell types following siRNA transfection. Beta actin expression is shown for both the control and targeted siRNA treated cells to confirm equal sample
loading.
doi:10.1371/journal.pone.0028123.g003
Mismatch Repair and Tumour Spheroids
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formation for one post-transfection passage only (P,0.05)
(Figure 5). MCTS numbers in both control and transfected N2a
cultures were seen to increase with passage number – consistent
with previous findings outlined in this paper.
Spheroid-derived cells exhibit enhanced MCTS growth
To assess whether MCTS cells undergo genetic or epigenetic
changes that enhance their ability to form MCTS we separated
spheroids from 7 day old cultures, dissociated them using non-
enzymatic cell dissociation solution and plated them as single cell
cultures onto new adhesive tissue culture plates. Non-spheroid
forming monolayer cells from the same cultures were plated at
equal density on separate plates. Spheroid-derived cells exhibited a
higher propensity to form new MCTS compared to non-spheroid
monolayer cells (Fig. 6).
Discussion
The work presented here is the first to causally link down-
regulated DNA MMR gene expression with the initiation and
development of MCTS in-vitro. We used silencing RNA (siRNA) to
knockdown expression of the MMR genes MLH1 and PMS2 in
surface-associated N2a and CHLA-02-ATRT cultures. Our data
show that silencing of these two genes results in an increase in the
number and size of MCTS that was observed over several
subsequent passages following transfection. The use of both
murine and human tumour cell lines eliminates the possibility of
the observations being species-specific.
Several possibilities exist to explain why impaired DNA MMR
enhances MCTS growth. MMR proteins serve to correct post-
replication errors by eliminating base-base mismatches and
insertion or deletion loops. An increase in spontaneous mutation
frequency resulting from an impairment of this system may give
rise to a range of beneficial and deleterious mutations. Such a
mechanism has been demonstrated by Nicolaides et al [30] who, in
an alternative approach to siRNA performed transfection studies
using a naturally occurring mutant hPMS2 identified from the
germline of a HNPCC patient. The nonsense mutation was
sufficient to suppress DNA MMR pathways and induce microsat-
ellite instability in cells containing wild-type hPMS2. Mutator
Figure 4. Silencing of MLH1 and PMS2 results in enhanced MCTS formation. N2a and CHLA-02-ATRT cells at 50% confluence were
transfected with 30 nM siRNA targeted against MLH1 and PMS2 and a negative control scrambled siRNA for a period of 5 hours. Cultures were
incubated under standard conditions for a further period of 4 days. MCTS number and size were determined by light microscopy and image analysis.
The silencing of MLH1 and PMS2 resulted in a significant increase in both the number (A) and size (B) of MCTS for both N2a and CHLA-02-ATRT cell
lines. Statistical differences were calculated by One Way ANOVA between the negative control and MLH1/PMS2 targeted siRNA cultures. Each bar
represents the mean +/2 s.e.m. for at least three independent experiments. Significant differences (P,0.05) are indicated by the asterisks (*). (C)
Representative low magnification light microscopy images showing cultures of N2a and CHLA-02-ATRT cells transfected with 30 nM negative control,
MLH1 and PMS2 targeted siRNA. MCTS appear as dense 3-dimensional structures as indicated by the arrows. Images were obtained 4 days post-
transfection. Scale bar represents 200 mm.
doi:10.1371/journal.pone.0028123.g004
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phenotypes of this kind represent an important model for cancer
development whereby mutant cells selected for their ability to
proliferate, while surviving environmental stresses, expand their
numbers and contribute to MCTS growth [18,31]. This
hypothesis is supported by data in this paper which reports that
spheroid-derived cells exhibit a higher propensity to form MCTS
compared to cells derived from the 2-D monolayer
However, MMR proteins have several functions other than
direct DNA repair that are relevant to genomic stability and
carcinogenesis. These include DNA damage surveillance, damage
signaling and apoptosis [24], prevention of recombination between
non-identical sequences [32,33] and participation in meiotic
processes (chromosome pairing) [33]. In addition there is now
evidence that the MMR system is integral to the signaling
processes that activate cell-cycle checkpoints or apoptosis.
Following DNA damage, cell cycle checkpoint activation halts
the cell cycle allowing time for DNA repair. Repair occurs in the
G1-S and G2-M phases. Previous studies have shown that
defective expression of MLH1 alters G2-M cell cycle checkpoint
control in human colon carcinoma cells exposed to ionizing
radiation [34]. Similar observations have been made in MLH1
deficient mice. Further work has suggested that MMR complexes
play a key role in linking Ataxia telangiectasia mutated (ATM) and
the downstream effector, CHK2 checkpoint homolog (CHEK2),
in response to DNA damage. CHK2 activation is lost in cells
deficient in MMR causing the G1-S checkpoint to fail. Such
interactions suggest a relationship between checkpoint signaling
activated by DNA damage and mechanisms of DNA repair. In
addition to the mutator phenotype associated with deficiency in
MMR, abrogated S-phase checkpoint activation may further
Figure 5. N2a and CHLA-02-ATRT cultures transfected with MLH1 siRNA continue to form higher numbers of MCTS following post-
transfection passage. Negative control and MLH1 siRNA transfected cultures were grown for 4 days post-transfection and analysed for MCTS
formation (passage number 0). Control and MLH1 transfected cultures were then scraped from the plate surface, treated with non-enzymatic cell-
dissociation, strained over a 70 mm filter to produce a single cell suspension and re-seeded as separate populations in new 60 mm dishes at a density
of 16103 cells per dish. MCTS number was analysed 7 days post passage. This procedure was repeated for a total of 3 passages. N2a MLH1 siRNA
transfected cultures were seen to retain an increased MCTS forming ability even after 3 passages. CHLA-02-ATRT MLH1 transfected cultures showed
an increased propensity to form higher numbers of MCTS for one post-transfection passage only. Each bar represents the mean +/2 s.e.m. for at least
three independent experiments. Significant differences (P,0.05) are indicated by the asterisks (*) and were calculated using the Student’s t-test.
doi:10.1371/journal.pone.0028123.g005
Figure 6. Spheroid-derived cells show an increased popensity
to form new spheroids. N2a and CHLA-02-ATRT MCTS were
separated from 7 day old cultures using the method described
previously in this paper. The MCTS and remaining non-spheroid-
forming monolayer cells were treated with non-enzymatic cell
dissociation solution to produce single cell suspensions and re-seeded
as separate populations into new 60 mm dishes at a density of 16103
cells per dish. Spheroid-derived cells exhibited a higher propensity to
form MCTS compared to monolayer-derived cells. Each bar represents
the mean +/2 s.e.m. for at least three independent experiments.
Significant differences (P,0.05) are indicated by the asterisks (*) and
were calculated using the Student’s t-test.
doi:10.1371/journal.pone.0028123.g006
Mismatch Repair and Tumour Spheroids
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explain the genomic instability and cancer predisposition arising
from inactivation of the MMR system.
It must also be stated that the MMR system can mediate
cytotoxicity. Down-regulation of MMR has been directly impli-
cated in the resistance of cancers to radiation and a number of
chemotherapeutic agents [35]. Impaired MMR results in drug
resistance through two mechanisms: the inability to detect DNA
damage and subsequent activation of apoptosis and through and
increase in mutation rate throughout the genome [36]. Further
studies to explore the clinical significance of MMR deficient cells
in tumours are needed.
Previous data has also suggested that human neuroblastoma cell
lines contain pluripotent tumour-initiating cells or ‘cancer stem
cells’ distinguished by CD133 (a neural stem cell marker)
expression [37]. Cancer stem cells have been seen to comprise
the majority of a tumour mass before terminal differentiation [38].
Current models of cancer development imply that genetic
instability and thus mutations directly affect normal stem cells
and their cellular pathways causing them to become malignant
[39–44]. In neuroblastoma CD133 positive cells show enhanced
MCTS formation [37]. It is therefore possible that down-regulated
DNA MMR may contribute to the genetic instability in stem cells,
promoting MCTS initiation and growth.
Consistent with reports on numerous other human and murine
cell lines grown as spheroids [5,19] we have demonstrated down-
regulation of MLH1 and PMS2 expression in N2a and CHLA-02-
ATRT MCTS compared with non-spheroid forming ‘monolayer
cells’. Recent evidence indicates that the expression of key DNA
MMR genes is down-regulated under conditions of hypoxic stress.
Hypoxia is a common feature of the tumour microenvironment,
arising from imbalances between oxygen supply and consumption.
Emerging evidence suggests that hypoxia-induced genetic insta-
bility is a key mechanism underlying tumour propagation.
Reynolds et al. [45] and more recently Papp-Szabo et al. [46]
have reported increased mutation frequencies in cells exposed to
hypoxia-reoxygenation cycles. Further studies have implicated
hypoxia in oxidative base damage [47,48], gene amplification [49]
and DNA over-replication [50]. Importantly for this present study
hypoxia has been implicated in the repression of nucleotide MMR
pathways and MLH1 down-regulation is specifically enhanced
under conditions of hypoxic stress [51]. Koshiji et al [52] have
since demonstrated the down-regulation of MSH2 and MSH6 in
response to hypoxia. Further alterations in the expression and
activation patterns of numerous DNA repair and stress-response
factors have been detected, however, the mechanisms responsible
for these observations remains to be determined. Further work in
our laboratory will examine the interrelationship between hypoxia
and genetic instability in the context of MCTS initiation and
development.
In summary our results show a deficiency of DNA MMR gene
expression in murine N2a and human CHLA-02-ATRT cells
grown as MCTS in comparison with 2D monolayer cultures. We
have shown that down-regulated DNA MMR results in enhanced
MCTS initiation and growth in N2a and CHLA-02-ATRT
surface-associated culture systems. This shows that down-regula-
tion of MMR can initiate and perpetuate the spheroid microen-
vironment, which can be an important initiating event in
malignancy. Additional work such as an in vitro DNA repair assay
(comparing the ability of cytosolic extracts to repair DNA
mismatches [53]) could functionally assess the level of DNA
mismatch repair activity in tumour spheroids or in the siRNA
transfected cells and provide a clearer understanding of the
processes that might be responsible for these findings. We believe
that by examining distinct MCTS and monolayer subpopulations
that arise during surface-culture of N2a and CHLA-02-ATRT,
this study has addressed pathways that lead to the initiation and
early differentiation of MCTS structures, thus providing new
insight into early events in tumourigenesis.
Materials and Methods
Cell and spheroid culture
Use of neuroblastoma and brain tumour cell lines for studies of
MCTS is well documented within the literature [5,19,37,54,55] and
the murine neuro-2a (N2a) and human CHLA-02-ATRT (intra-
cranial atypical rhabdoid tumour) cell lines readily form MCTS in
our experimental system. The C1300 mouse N2a cell line [56] was
obtained from the American Type Culture Collection (Manassas,
VA, USA) at passage number 182. Any reference to passage
number in the text refers to this number plus the given ‘P’ number.
This cell line was maintained in minimal essential medium (MEM)
(Invitrogen, Paisley, United Kingdom) supplemented with 10%
foetal bovine serum (FBS) (Biosera, Ringmere, United Kingdom),
10% penicillin-streptomycin mix and 10% glutamine at 37uC and
in an humidified atmosphere of 5% CO2. CHLA-02-ATRT cells
were obtained from the ATCC at passage number 7. Any reference
to the passage number in the text refers to this number plus the
given ‘P’ number. This cell line was maintained in DMEM:F12
medium supplemented with 10% foetal bovine serum, 10%
penicillin-streptomycin mix, 20 ng/mL human recombinant EGF,
20 ng/mL human recombinant basic FGF (R&D Systems,
Abingdon, United Kingdom) and 2%B-27 supplement (Invitrogen).
Murine 3T3 cells were maintained in MEM supplemented with
10% foetal bovine serum, 10% penicillin-streptomycin mix and
10% glutamine. Media were replaced every 3 days until cells had
achieved 70% confluence and then every 2 days thereafter. At
approximately 85% confluence, cell cultures were passaged by
washing with sterile 16Dulbecco’s Phosphate Buffered Saline (D-
PBS) without calcium and without magnesium and treating with
TrypLE Express solution (Invitrogen) for 5 minutes at 37uC and 5%
CO2. The resulting cell suspension was pelleted, the supernatant
removed and cells resuspended in fresh warmed medium before
reseeding in T75 flasks (Nunc, Roskilde, Germany) at a final
concentration of 26105/ml.
MCTS were generated by seeding 16103 cells/plate on
Nunclon D Surface coated 60 mm tissue culture plates (Nunc).
Spheroids formed spontaneously over a period of 3–7 days. Media
were changed according to cell confluence as previously described.
Where indicated 26104 cells/well were plated on 90 mm pre-
coated plates (Nunc) to scale up the experiment.
Removal and dissociation of spheroids
Individual spheroids were ‘picked’ from the plate surface using a
19-gauge Microlance needle under a Leica MZ16F dissection
microscope and transferred to pre-warmed appropriate media.
Spheroids were dissociated into single cells using non-enzymatic
dissociation solution (Sigma, Poole, United Kingdom) and strained
over a 40 mm filter. The remaining monolayer cells were trypsinised
from the plate surface and transferred to pre-warmed media. Both
suspensions were pelleted at 3000 rpm for 3 minutes, and
resuspended in fresh pre-warmed media. Culture plates were then
seeded with 16103 spheroid or monolayer derived cells per plate and
incubated at 37uC and 5% CO2. Media were changed according to
cell confluence. Spheroid formation was analysed after 7–10 days.
Image analysis and spheroid quantification
A Leica dissection microscope with attached Canon Powershot
A470 digital camera was used to image and quantify all spheroids
Mismatch Repair and Tumour Spheroids
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in 60 mm and 90 mm plates. For higher magnification images a
Nikon Diaphot inverted microscope was used with attached Nikon
D50 digital camera. Spheroid number and size was determined
through image analysis using the NIH ImageJ software package.
siRNA transfection
For RNA interference siRNA molecules were purchased from
Ambion (Warrington, United Kingdom), two targeted against
murine MLH1 (157141 and 81233), one against murine PMS2
(571891), two against human MLH1 (s224048 and S298), one
against human PMS2 (s10740) and a negative control scrambled
siRNA. Unless otherwise indicated all transfections were per-
formed with a final concentration of 30 nM siRNA.
N2a and CHLA-02-ATRT cells were seeded at 16103 per plate
into pre-coated 60 mm plates in a total volume of 4 mL MEM and
incubated for 2–4 days until 50% confluent. Transfections were
performed using INTERFERinTM transfection reagent (Polyplus,
New York, USA) as per the manufacturer’s instructions. Briefly
siRNA complexes were prepared as aqueous solutions by adding
the appropriate volume of siRNA to 200 ml warmed serum-
free MEM media. 10 ml INTERFERinTM was added to each
preparation and solutions incubated at room temperature for
10 minutes. Media were replaced with fresh MEM without
antibiotics to which was added the siRNA-INTERFERinTM
complexes to a total volume of 2 ml. Media containing the
transfection agent was aspirated after 5 hours and replaced with
fresh antibiotic-containing media.
RNA isolation and cDNA synthesis
Total RNA was isolated using an RNeasy Mini kit (Qiagen,
Crawley, United Kingdom) as described in the manufacturer’s
instructions. The extracted RNA was then used immediately or
stored at 280uC until required. One mg of total RNA from each
experimental set was prepared using a Nanodrop ND1000
machine (Thermo Scientific, Wilmington, USA) and used for
cDNA synthesis. Reverse transcription of isolated RNA was
achieved using the ImProm-II Reverse Transcription System
(Promega, Southampton, United Kingdom) and oligo-dT primers.
PCR and analysis of gene knockdown
cDNA were amplified by PCR using the GoTaq Green Master
Mix kit (Promega) with specific primers for the amplification of
murine and human MLH1 and PMS2.
Sequences were as follows: Murine MLH1 sense 59-AGCAG-
CACATTGAGAGCAAG-39, antisense 59-GCTTACAGGCTG-
CAGAAAGG-39 (224-bp product), murine PMS2 sense 59-C-
CAAGTGAGAAAAGGGGCGTGTTATCC-39, antisense 59-C-
TGTCTTGAAGCGCTTGGCATTTGTG-39 (394-bp product),
human MLH1 sense 59-GAGACAGTGGTGAACCGCAT-39,
antisense 59-CTTGATTGCCAGCACATGGT-39 (403-bp prod-
uct) and human PMS2 sense 59-AGAACCTGCTAAGGCCA-
TCA-39, antisense 59-TAAGCCTTCGAAGTTTTCTTCTT-39
(233-bp product) [51]. For b-actin, the Mouse/Rat b-Actin primer
pair (RnD Systems, Abingdon, UK) was used (302-bp product).
PCR was conducted using an MJ Mini thermocycler (BioRad,
Hemel Hempstead, United Kingdom).
PCR products were visualised by gel electrophoresis using a
1.5% agarose gel. Image acquisition of detected bands was carried
out using a Genius Bio Imaging System (Syngene, Cambridge,
United Kingdom).
Statistical Analysis
All data were expressed as means 6 s.e.m. for at least three
independent experiments and analysed by One Way ANOVA or
the Student’s t-test Significant differences are indicated in the
figures by an asterisk. SigmaStat 3.5 software was used to perform
statistical tests.
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